Study | Time points | Primary end point and symptom scoring | Improvement in primary end point | Specific symptoms correlating with primary end point |
Dear 2005 | Last 7 days flagyl or fibre reduction | Composite score, 6 symptoms | 38% vs 33% | Bloating |
Wind | ||||
Sharara 2006 | 10 days post-rifaximin or placebo | Global improvement, 15 symptoms | 29% vs 12% | Bloating |
Pimentel 2006 | 10 week period post-rifaximin or placebo | Global improvement, 4 symptoms | 36% vs 21% | Bloating |
Di Stephano 2000 | 10 days post-rifaximin or placebo | Global improvement, 5 symptoms | 44% vs 2% | Flatus |
Abdominal girth |